Tefinostat

N/A

Report date: 2024/11/02 20:00:07
NME

Base Information

Drug NameTefinostat
Drug Alias Name特诺司他tefinostattefinostatumTefinostat tartrateCHR-2845
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsHematologic DiseasesCarcinoma, HepatocellularLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlandsUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChroma Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChroma Therapeutics LtdQueen Mary University Of London
Active IndicationsN/A
Inactive IndicationsHematologic DiseasesCarcinoma, HepatocellularLymphoma

Other Information

ATC CodeN/A
Related LinksN/A